Acarbose itself does not cause hypoglycemia even when administered to patients in the fasted state. Sulfonylurea drugs and insulin, however, can lower blood sugar levels enough to cause symptoms or sometimes life-threatening hypoglycemia. Because acarbose given in combination with sulfonylurea or insulin will cause a further lowering of blood sugar, it may increase the hypoglycemic potential of these agents.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
